Live Attenuated Rift Valley Fever Vaccine for Single Shot Administration (LARISSA)

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501460-17-00

Acronym

LARISSA

Enrollment

Registered

2022-07-26

Start date

2022-07-26

Completion date

Unknown

Last updated

2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rift Valley fever (RVF) infection

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 6, 2026